The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease
Julius Wilder,1,2 Keyur Patel1,21Division of Gastroenterology, Duke University School of Medicine, 2Duke Clinical Research Institute, Durham, NC, USAAbstract: An important aspect of managing chronic liver disease is assessing for evidence of fibrosis. Historically, this has been accomplished using...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/beb8e85e185041509442cefbb2ee8b35 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:beb8e85e185041509442cefbb2ee8b35 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:beb8e85e185041509442cefbb2ee8b352021-12-02T11:41:52ZThe clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease1179-1470https://doaj.org/article/beb8e85e185041509442cefbb2ee8b352014-05-01T00:00:00Zhttp://www.dovepress.com/the-clinical-utility-of-fibroscanreg-as-a-noninvasive-diagnostic-test--a16649https://doaj.org/toc/1179-1470 Julius Wilder,1,2 Keyur Patel1,21Division of Gastroenterology, Duke University School of Medicine, 2Duke Clinical Research Institute, Durham, NC, USAAbstract: An important aspect of managing chronic liver disease is assessing for evidence of fibrosis. Historically, this has been accomplished using liver biopsy, which is an invasive procedure associated with risk for complications and significant sampling and observer error, limiting the accuracy for determination of fibrosis stage. Hence, several serum biomarkers and imaging methods for noninvasive assessment of liver fibrosis have been developed. In this article, we review the current literature on an important noninvasive imaging modality to measure tissue elastography (FibroScan®). This ultrasound-based technique is now increasingly available in many countries and has been shown to be a reliable and safe noninvasive means of assessing disease severity in chronic liver disease of varying etiology.Keywords: elastography, ultrasound, fibrosis, cirrhosisWilder JPatel KDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2014, Iss default, Pp 107-114 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medical technology R855-855.5 |
| spellingShingle |
Medical technology R855-855.5 Wilder J Patel K The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| description |
Julius Wilder,1,2 Keyur Patel1,21Division of Gastroenterology, Duke University School of Medicine, 2Duke Clinical Research Institute, Durham, NC, USAAbstract: An important aspect of managing chronic liver disease is assessing for evidence of fibrosis. Historically, this has been accomplished using liver biopsy, which is an invasive procedure associated with risk for complications and significant sampling and observer error, limiting the accuracy for determination of fibrosis stage. Hence, several serum biomarkers and imaging methods for noninvasive assessment of liver fibrosis have been developed. In this article, we review the current literature on an important noninvasive imaging modality to measure tissue elastography (FibroScan®). This ultrasound-based technique is now increasingly available in many countries and has been shown to be a reliable and safe noninvasive means of assessing disease severity in chronic liver disease of varying etiology.Keywords: elastography, ultrasound, fibrosis, cirrhosis |
| format |
article |
| author |
Wilder J Patel K |
| author_facet |
Wilder J Patel K |
| author_sort |
Wilder J |
| title |
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| title_short |
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| title_full |
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| title_fullStr |
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| title_full_unstemmed |
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease |
| title_sort |
clinical utility of fibroscan® as a noninvasive diagnostic test for liver disease |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/beb8e85e185041509442cefbb2ee8b35 |
| work_keys_str_mv |
AT wilderj theclinicalutilityoffibroscanregasanoninvasivediagnostictestforliverdisease AT patelk theclinicalutilityoffibroscanregasanoninvasivediagnostictestforliverdisease AT wilderj clinicalutilityoffibroscanregasanoninvasivediagnostictestforliverdisease AT patelk clinicalutilityoffibroscanregasanoninvasivediagnostictestforliverdisease |
| _version_ |
1718395423838699520 |